Acquired CDK6 amplification has resulted in breast cancer resistance to CDK4/6 inhibitors [21]; however, the reason for CDK6 overexpression resulting in resistance to CDK4/6 inhibitors remains unclear. This evidence concerns the gene CDK4 and breast cancer.